Cite
Pharmacokinetics of GS-441524, the active metabolite of remdesivir, in patients receiving continuous renal replacement therapy: A case series.
MLA
Nishikawa, Asami, et al. “Pharmacokinetics of GS-441524, the Active Metabolite of Remdesivir, in Patients Receiving Continuous Renal Replacement Therapy: A Case Series.” Journal of Infection & Chemotherapy (Elsevier Inc.), vol. 30, no. 4, Apr. 2024, pp. 348–51. EBSCOhost, https://doi.org/10.1016/j.jiac.2023.10.015.
APA
Nishikawa, A., Ito, I., Yonezawa, A., Itohara, K., Matsubara, T., Sato, Y., Matsumura, K., Hamada, S., Tanabe, N., Kai, S., Imoto, E., Yoshikawa, K., Ohtsuru, S., Yanagita, M., Hirai, T., & Terada, T. (2024). Pharmacokinetics of GS-441524, the active metabolite of remdesivir, in patients receiving continuous renal replacement therapy: A case series. Journal of Infection & Chemotherapy (Elsevier Inc.), 30(4), 348–351. https://doi.org/10.1016/j.jiac.2023.10.015
Chicago
Nishikawa, Asami, Isao Ito, Atsushi Yonezawa, Kotaro Itohara, Takeshi Matsubara, Yuki Sato, Katsuyuki Matsumura, et al. 2024. “Pharmacokinetics of GS-441524, the Active Metabolite of Remdesivir, in Patients Receiving Continuous Renal Replacement Therapy: A Case Series.” Journal of Infection & Chemotherapy (Elsevier Inc.) 30 (4): 348–51. doi:10.1016/j.jiac.2023.10.015.